Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät

7680689460024 CH-68946 Injektionslösung
Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät
Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/05/2025
Patient information leaflet
Français
29/05/2025
Patient information leaflet
Italien
29/05/2025
Summary of Product Characteristics
Allemand
29/05/2025
Summary of Product Characteristics
Français
29/05/2025
Summary of Product Characteristics
Italien
29/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
180.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.25 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2343.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
68946
Drug name
Skyrizi, Injektionslösung in einer Patrone für ein Dosiergerät
Galenic form
LSILPD
ATC Code
L04AC18
Authorization status
Z
Dispensing category
B
First authorization
14/09/2023
Authorization expiration date
13/09/2028
IT Number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn und Colitis ulcerosa bei Erwachsenen

Package details

Description (FR)
SKYRIZI sol inj 180 mg 1 pce
Description (DE)
SKYRIZI Inj Lös 180 mg 1 Stk
Market launch
14/02/2025
Market withdrawal
13/09/2028
Narcotic (BTM)
No

Other package sizes (1)

SKYRIZI sol inj 360 mg/2.4ml cartouche 2.4 ml
1 STU
GTIN: 7680689460017
View